HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chondroitin sulfate protects vascular endothelial cells from toxicities of extracellular histones.

Abstract
Extracellular histones induce lethal thrombosis by promoting platelet aggregation, neutrophil migration, and cell injuries. Heparin, which has negative charges, can bind to extracellular histones; however, heparin strongly inhibits the activation of coagulation. Since chondroitin sulfate (CS) shows less effect on the coagulation system than heparin does, CS has the potential to become an effective drug for lethal thrombosis with high risk of bleeding. To elucidate the therapeutic mechanisms of CS in lethal thrombosis, we investigated the interaction between CS and extracellular histones. Mouse vascular endothelial cells were incubated with histones in the presence of heparin or CS, and the expression of caspase-3/7 was measured. The interactions between histones and heparin or CS were measured by surface plasmon resonance analysis. Vascular permeability, platelet counts, liver and renal functions, and coagulation times were evaluated in an in vivo assay. The apoptosis induced by histones was inhibited by treatment with heparin or CS. Heparin and CS showed strong binding to histones and inhibited vascular hyperpermeability. The platelet counts as well as liver and renal functions were not decreased by the treatment with heparin or CS. Moreover, CS showed less effect on the coagulation system than heparin did. These results suggested that CS can be a novel agent for lethal thrombosis with the risk for hemorrhage. Since vascular endothelial cell injuries occur at an early stage of lethal thrombosis, administration of CS might be a useful approach.
AuthorsFumihiko Nagano, Tomohiro Mizuno, Shuji Mizumoto, Kengo Yoshioka, Kazuo Takahashi, Naotake Tsuboi, Shoichi Maruyama, Shuhei Yamada, Tadashi Nagamatsu
JournalEuropean journal of pharmacology (Eur J Pharmacol) Vol. 826 Pg. 48-55 (May 05 2018) ISSN: 1879-0712 [Electronic] Netherlands
PMID29501579 (Publication Type: Journal Article)
CopyrightCopyright © 2018 Elsevier B.V. All rights reserved.
Chemical References
  • Anticoagulants
  • Histones
  • Heparin
  • Chondroitin Sulfates
Topics
  • Animals
  • Anticoagulants (pharmacology, therapeutic use)
  • Blood Coagulation (drug effects)
  • Capillary Permeability (drug effects)
  • Chondroitin Sulfates (pharmacology, therapeutic use)
  • Disease Models, Animal
  • Endothelial Cells (drug effects)
  • Hemorrhage (blood, etiology, prevention & control)
  • Heparin (pharmacology, therapeutic use)
  • Histones (metabolism)
  • Humans
  • Male
  • Mice
  • Mice, Inbred DBA
  • Platelet Aggregation (drug effects)
  • Platelet Function Tests
  • Surface Plasmon Resonance
  • Thrombosis (blood, drug therapy, etiology)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: